Reierson, Gillian W.Mastronardi, ClaudioLicinio, JulioWong, Ma-Li2015-12-080304-3940http://hdl.handle.net/1885/35270Cyclic adenosine monophosphpate (cAMP) signaling is thought to be involved in the pathophysiology of major depressive disorder and antidepressant action; however, relatively little is known about the possible role of cyclic guanosine monophosphate (cGMP)Keywords: amitriptyline; antidepressant agent; cyclic GMP; fluoxetine; phosphodiesterase; animal experiment; animal tissue; article; controlled study; drug effect; drug efficacy; drug mechanism; gene expression; hippocampus; male; nonhuman; nucleotide sequence; pri Antidepressant; Cyclic; Hippocampus; Nucleotides; Phosphodiesterase; Rat200910.1016/j.neulet.2009.09.0472016-02-24